Announced
Completed
Synopsis
General Atlantic, a private equity firm, led a Series B round in Javara, an integrated research organization and a pioneer of clinical research as a care option. Financial terms were not disclosed. “We founded Javara with a vision to transform clinical research delivery, creating a business and technology framework whereby clinical trials are on the menu of care options for all patients within the entire healthcare system. Our focus in pioneering this innovative approach was – and remains – to create a model that drives value across the industry for all stakeholders, while ensuring all patients have the access to the care they deserve. We have worked with great urgency and intentionality to address the long-standing barriers in the industry impacting patient access and participation in clinical research, and we are thrilled to partner with General Atlantic to bring forth more investigators, increase diversity and more effectively address the unmet need of patients through the delivery of clinical research as a care option. General Atlantic brings a breadth of experience in the healthcare and life sciences space – a landscape ripe with possibilities for innovation and technology enablement – and their commitment to seeking and realizing opportunities to advance clinical research is truly invaluable to our organization and our industry as we look to the future,” Jennifer Byrne, Javara CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.